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An Anthropological Study of TB and
Biomedical Strategies for TB Control
The recent re-emergence of
tuberculosis cases in various parts of the
developed world has been viewed by many as
the resurrection of a demon of the past- the
rebirth of a disease believed to have been
vanquished by the all-powerful curatives of
modem medicine. The discovery of efficacious
TB drugs in the early 1940s and ]950s led to
the widespread closure of TB sanatoria in
developed countries, spurring the belief (in both
lay individuals and medical professionals alike)
that tuberculosis could be eliminated once and for
all, like other devastating diseases such as polio
and smallpox. However, the optimism of the
]950s has been seriously challenged by a global
upsurge in TB case findings which has steadily
increased since the ]980s. The increasing number
of TB cases worldwide has led both those in the
academic and medical community to ask the
question: "Why does tuberculosis continue to
threaten the lives of millions of people around the
world, when a cure for the bacteria which causes
the disease has been found?"
Tuberculosis continues to be the leading
cause of death of adult men and women- a fact
that has spurred the World Health Organization
(WHO) to lightfully declare the rampant
transmission of TB as a global health emergency
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(WHO 1997). In an effort to reduce TB
morbidity and mortality, the WHO has
reconm1ended a standardized strategy for TB
control to eradicate the spread of the disease on
a global scale. Known as the DOTS strategy for
TB control, the WHO strategy consists of five
key elements. Of these components, it is the
practice of Direct Observation Therapy (DOT),
a form of treatment based on the supervised
patient ingestion of TB drugs which has
received the most publicized attention and merit
as a means of eradicating tuberculosis on a
global scale (WHO 1997).
The emphasis on directly observed
therapy as the most efficacious component of
TB control programs has presented a number of
problems in the field of TB research. The
application of a strictly biomedical approach to
the prevention and treatment of disease is a
function of the ideology and principles of the
capitalist system, which places great emphasis
on the superiority of Western medical
knowledge and biotechnology as the panaceas
to human misery. Current TB elimination
initiatives, including the exaltation of short-term
chemotherapy as the "be all and end all" of TB
control may be problematized at both a
theoretical and a methodological level. From a
theoretical standpoint, medical anthropologists
view the pronounced emphasis on
pharmacological solutions to disease as a lucid
example of biomedicine as a hegemonic force in
the world system- where the dominant paradigm
for the conceptualization, diagnosis and
treatment of disease accords authority to
medical practitioners and biomedical
interventions, to the exclusion of pluralistic
medical systems. The priority and pre-eminence
of biological phenomena and explanations in
the Western medical paradigm is also viewed as
a subversive means of de-politicizing health and
illness. By focusing exclusively on quantitative
biological measures of "health" (i.e. the
pathogenesis, etiology, and epidemiology of
disease), and by directing focus on the
bacterium itself, biomedical discourse and the
space within which it is mticulated precludes
serious discussion and debate on the underlying
political and socio-economic forces that affect
one's health and well-being. Meanwhile, the
application of a generic TB strategy as a
universal guideline for TB control hinders the
creation and implementation of population
specific, culturally-appropriate, socially and
politically-contextualized health policies and
lrutlatIves on an international, national, and
regional level.
At the methodological level, mounting
studies on DOTS as a sole course of action in the
treatment of TB have called the efficacy of DOT-
centered strategies into question. Emphasis on
one strategy goes against the multiple components
recommended by the WHO strategy. The
publicized success of DOT as an exclusive course
of action provides a false view of its efficacy, as
the implementation of many DOT initiatives have
necessarily included parallel strategies that have
been identified as working in concert in
successful TB control programs.
In light of these emerging clitiques, this
study strives to approach the study of tuberculosis
from an anthropological perspective. The goal of
this paper is threefold: I) to acquaint the reader
with current global initiatives designed to control
the dissemination of TB; 2) to offer a synthesis of
clitiques from -both biomedical researchers and
social scientists on the underlying weaknesses and
failures of current TB elimination strategies; and
3) to situate and interpret the shortcomings of the
various elements that constitute TB control
strategies within the dominant Western
biomedical pm·adigm. A preliminary framework
for analysis based on the principles of "critical
medical anthropology" shall be used as an
example of how alternative theoretical approaches
can shed light on the number of converging
variables that contribute to the differential
distribution of the disease within populations.
Finally, the current strategy for the eradication of
tuberculosis in Canadian AbOliginal populations
shall be elicited as a case example to illustrate
how the dismissal of structural violence and
historical contingency represent major
shortcomings of controlling TB in First Nations
populations.
On a global level, TB occupies the ranks
of other diseases such as dysentery and malaria,
commonly categorized as "neglected diseases"- a
term loosely used to describe pathological
conditions which despite their continued
virulence, transmission. and devastating effects
on the morbidity and mOltality of large
populations on a large scale. continue to be under-
represented as a major health concern in public
health policies, campaigns and the mainstream
media. The absence of sufficient discourse and
successful intervention strategies with respect to
these diseases has been attributed to the
prevalence of diseases such as TB among
impoverished and disenfranchised urban and rural
populations. However, contrm'y to representations
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of TB as a health problem of underdeveloped
countlies, there is growing evidence of the "re-
emergence" of tuberculosis in highly
industlialized societies. Global
interdependency, rapid transportation,
expanding trade, economic disparities and
changing social and cultural patterns have all
been identified as factors which have influenced
the epidemiology of TB, making tuberculosis
epidemics in any country a serious global health
concern (Squire and Wilkinson 1998:469). The
synergy of tuberculosis and HIV co-infection
has introduced a new wave of the disease,
affecting populations as diverse as African rural
communities, prison populations and the urban
homeless of industlialized nations.
Direct Observation Therapy (DOT)
The control of tuberculosis is a leading
public health priority worldwide. WHO
declared tuberculosis a global health emergency
in 1993 and launched the Directly Observed
Therapy Supervision Program (DOTS) for TB
control (WHO 1988). There are five basic
elements of the WHO TB control strategy: I)
government conmutment to TB control; 2)
passive case finding and diagnosis with smear
nucroscopy; 3) standard, short-course
chemotherapy with direct observation of the
treatment (DOT); 4) continuous and reliable
supply of quality drugs; and 5) an efficient
recording and reporting system (WHO 1988).
Directly observed therapy (DOT),
plays an important role in the WHO TB
eradication strategy, and has been heralded as a
new breakthrough in tuberculosis control.
However, as astutely observed by Squire and
Wilkinson (1998) DOT is a method "as old as
TB chemotherapy itself', emerging at a time
when TB therapy evolved from treatment based
upon long-term institutionalization, to one
based upon more flexible, patient-centered care
(Squire and Wilkinson 1998:469). With the
implementation of ambulatory therapy, there
also arose the problem of patient adherence to
treatment; an issue which continues to challenge
TB elimination strategies to the present day.
The very issue of patient non-compliance and
the consequences which can result from
incomplete treatment regimens (mainly the
dissemination of the disease from infected
patients and the drug resistance that results from
the premature cessation of TB chemotherapy),
in addition to the difficulties associated with
controlling tuberculosis among HIV -infected
persons, and the rapid increase in the number of
cases, especially in metropolitan areas led to the
creation of directly observed therapy as a form of
medical intervention. Yet, the question remains: is
DOT a tmly efficacious means of eradicating TB?
Evaluation of DOTS strategies in the last few
years from those within the medical community
as well as scholars of social medicine seems to
point to the contrary.
Critiques of Current TB Eradication Initiatives
Since its implementation in the early
1990s. there has been a great deal of debate over
the efficacy of TB control strategies. One major
cliticism of the DOTS strategy is that it is based
upon the "control of the patient". The emphasis
on patient adherence and compliance, in addition
to other authOlitarian and often pUlutive measures
(such as enforced detention of non-compliers) are
beginning to shed light on the ethical and socio-
political issues entwined in the DOTS debate.
Gostin's review of TB statutes in 50 states during
a time of national concern over rising TB case
findings in the US draws attention to some of the
ethical issues related to TB control. Improving
respect for TB patients and implementing
individualized plans of treatment that are
reinforced by adequate supp0l1 structures are two
courses of action that can lead to the creation of
more humane and successful TB control strategies
(Gostin 1993). Gostin' s sentiments are echoed in
recommendations made by health care
professionals, who agree that a healthy
infrastructure. and not increased control of patient
behaviour is necessary for successful TB control
initiatives.
It has also come to the attention of
several medical researchers that despite DOTS
reputation as a successful means of treating TB
and impeding the disease' s dissemination. it
should not be seen as a sole method of treating the
disease, as it represents (more often than not) one
component of successful TB programs. As
observed by Bloch et al. (1994) in their analysis
of the TB trend between 1993 and 1995, TB
successes were most likely to be the result of
multiple components acting in concert to support
and enable patients to complete therapy.
Co-Interventions in DOTS programs
New insights into the heterogeneous.
multi-factoral and multifaceted aspects of DOT-
centered programs have become available in the
last few years from within the very medical
community which exalted it. One such critique
comes from Volmink et al. (2000) who
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appropriately highlight the importance of
program components such as incentives,
outreach eff0l1s, and attention to individual
patients' issues. In their review of published
rep0l1s on directly observed therapy programs,
the authors observed that the programs
consisted in fact of more than the reconunended
five elements of the WHO strategy. Additional
"co-interventions" included: incentives, tracing
defaulters, legal sanctions, patient-centered
approaches. staff moti vation, supervision, and
additional external funding. In one study of the
effectiveness of a conununity-based DOTS
program in a Bangladesh village (Barnnhorn &
Adl;aanse 1992:297), interventions offered to
patients in addition to direct observation
included contracts, free drug education.
monetary incenti ves, and other services from
health workers (e.g. immunizations,
improvements in water and sanitation, family
planning). Monetary incentives, supervision,
and profits from the sale of TB drugs were
among the incentives offered to staff in charge
of supervising the DOTS program. while
external funding, improved records, conmlUnity
education about tuberculosis and strengthening
of diagnostic services monitoring were but a
few of the additional factors influencing the
success of the particular DOTS program in that
region. In highlighting these imp0l1ant co-
interventions in DOT programs, the authors
wish to underscore the fact that directly
observed therapy cannot be viewed as a
successful course of TB intervention in and of
itself. This being said, Volmink et al. bl;ng
attention to the fact that the World Health
Organization ought to be more explicit in
describing and differentiating the efficacy of the
DOTS strategy (which consists of the WHO's
five major reconunendations for TB control)
and the DOT strategy of supervised patient drug
ingestion (Volmink et al. 2000).
Studies such as those of Volmink
represent an increasing reflexivity toward
research by those in the biomedical field.
Although promising, medical researchers and
practitioners still have a long way to go in the
area of critically assessing the efficacy of
biomedical interventions in disease control. The
most important step toward a more reflexive
process of scientific research needs to begin
with a reassessment of the very tools utilized for
the collection of data. The universal
applicability and accuracy of randomized
control tIials (RCT) for example, is a topic that
continues to be debated in the scientific sphere.
Yet, despite recent acknowledgment of the
limitations of the RCT for measuring the success
of medical interventions, this methodological tool
continues to be utilized as the main method of
gatheling statistically significant quantitati ve
data. Secondly, medical practitioners still need to
come to terms with the fact that there is no
'golden standard" by which to measure patient
adherence to anti-tuberculosis drngs.
An accurate view of the success of
DOTS programs and other initiatives can only be
attained by consideling the host of context-
specific factors that shape and influence both the
strategy that is implemented and the course of
action taken by the actors involved. To achieve
this alternative "standpoint", it is necessary to
move beyond the theory and praxis of the
biomedical paradigm. This of course is not an
evocation for the dismissal or abandonment of the
knowledge accrued through the teachings and
methods of- Western medicine. It is rather a
cOllill1entary on the need to shift the emphasis
from the bacterium and its prescribed chemical
curative, to analyses which focus on the
socioeconomic factors and social behavioural and
cultural elements; important variables which
inevitably influence one' s decision-making and
course of action with regards to health-seeking
behaviour and adherence to treatment. The first
step in this type of critique involves identifying
the hegemonic aspects of biomedicine, and how
they relate to the area of TB prevention and
treatment.
The Hegemony of Biomedicine
A useful definition of biomedicine is
given by Hahn (1983) who describes the
biomedical field as one which distinguishes itself
from other healing systems "by vil1ue of its
exclusive focus on human physiology, and more
specifically, human pathophysiology when
diagnosing and treating illness (Singer & Baer
1995: 14). By adopting a biological reductionist
position in the area of health care diagnosis and
delivery, and promoting the dichotomy of mind
and body in classic Cm1esian fashion,
biomedicine may be viewed as a system that is
more concerned with diseased bodies than with
the health and well-being of individuals (Singer &
Baer 1995:16). A defining feature of the Western
medical model is the process of medicalization, a
term used to describe the "absorption of a wide
social m"enaof behaviour under the jurisdiction of
the medical role" (Singer & Baer 1995: 16). This
process is evidenced by the endless list of
pathological terminology used to designate and
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categorize a wide array of "new" conditions and
behaviours (Singer & Baer 1995: 16). The
motives for the perpetuation of the
medicialization process may be viewed as
emerging from the economic advantages that
come from the diagnosis of new diseases and
prescriptions of new drugs and the increase
social control that this process accords to health
care professionals over social behaviour (Singer
& Baer 1995: 18). The increasing medicalization
of life events exemplifies biomedicine' s attempt
to "transform a problem which occurs at the
level of social structure into an administrative
problem which comes under the jurisdiction of
medical control" (Singer & Baer 1995: 18).
To understand the underlying factors
which contIibute to the pre-eminence and far-
reaching tentacles of biomedicine, it is
necessary to identify the political underpinnings
that have shaped the theory and praxis of
Western (allopathic) medicine. The history of
allopathic medicine and its dominance in the
world system is intimately connected to the
emergence of industlial capitalism and the
ruling capitalist class which it was created to
serve.
Philanthropic organizations, like the
Carnegie and Rockefeller foundations represent
institutions that played a major role in shaping
the priorities and practice of modern medicine
by allocating resources to research projects that
conformed to an accepted Western scientific
paradigm (i.e. the germ theory of disease),
promoted biotechnological solutions to health
problems, and which conferred either political
and/or economic advantages to the funding
agencies involved (Singer & Baer 1995:20). As
noted by Brown (1979) the medical profession
discovered an ideology which was "compatible
with the world view that was politically and
economically useful to the capitalist class, and
the emerging managerial and professional
stratum" (Singer & Baer 1995:20). Marxist
critiques of the biomedical system point to the
underlying economic agenda of its proponents,
which is based on improving the working
class's economic productivity. Biomedical
theOlies of disease phenomena correspond to
the principle and objectives of the capitalist
social system by promoting a reductionist and
mechanistic view of individuals. Refen'ed to as
medical hegemony, this defining characteristic
of the Western biomedical model reflects the
ideological machine which facilitates and
supports the process of medicalization and
promotes the reproduction of social hierarchies
that maintain disparate distIibutions of power and
resources in the political, economic and social
spheres (Singer & Baer 1995:20).
The term "medical hegemony" is based
on Antonio Gramsci' s articulation of the power of
the ruling class' s ideology over the existing social
system. The concept is an extension of Marx and
Engel's observation that "the ideas of the ruling
class are in every age the ruling ideas", and is
used in referring directly to the process by which
capitalist assumptions, attitudes and values come
to permeate medical diagnosis and treatment
(Singer & Baer 1995:20). Upon closer
examination, one can discern a number of
capitalist beliefs, values and principles embedded
in the biomedical paradigm. These include: a
strong emphasis on self-reliance, individualism,
pragmatism. emotional detachment, maintaining
the mindlbody dichotomy, the upholding of
stratified social classes and permeation of
economic opportunism (Singer & Baer 1995:20).
Having outlined the basic features of
Western biomedicine, one can proceed to identify
the features of medical hegemony in TB
eradication initiatives. CIitical medical
anthropology represents one theoretical
framework which may be used to identify the
hegemonic aspects of allopathic medical
strategies. Singer & Baer (1995:12) have
operationalized the clitical medical anthropology
theoretical perspective as one which
"understands health issues
within the context of
encompassing political and




local ecologies, and situate
cultural meanings, including
forces of institutional, national
and global scale. The
emergence of critical medical
anthropology reflects both the
turn toward politico-economic
approaches in anthropology in
general. as well as an effort to
engage and extend the political
economy of health approach."
This theoretical OIientation may be seen as
emerging in response to the increasing
fragmentation in the sub-discipline of medical
anthropology in general. Ongoing debates in the
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sub-field over theoretical, ideological and
methodological issues are diverse, but for the
sake of simplicity, may be taxonomized into
roughly three schools of thought. On one side
of the debate, are those who call for a more
thorough integration with biomedicine, which
prevails as the golden standard in the discourse
on health and illness. Diametrically opposed to
this view are those who admonish the
increasing medicalization of medical
anthropology and the expansion of biomedical
authOlity and jurisdiction over other aspects of
social life and the continuing incorporation of
Western medical assumptions in
anthropological inquiry (Singer & Baer
1995: 12). Seen as a more radical approach, this
"interpretive" calls for the creation of a new
phenomenology which allows for the study of
sufferers expelience "independent of the
biomedical categOlizations of illness" (Singer
& Baer 1995: 13).
Critical medical anthropology takes
biomedicine as its starting point in its attempt to
"understand the power relations, dynamic
processes and systemic stmctures that shape and
control the dominant medical system and to
assess the implication of such control" (Singer
& Baer 1995: 12-13).
Medical Hegemony in TB Control and its
Implications
DOT: One recommendation out of many?
The assortment of challenges posed by
the implementation of DOTS on a global level
may be seen as stemming from both
methodological and theoretical
concerns/problems. Over-emphasis on directly
observed therapy has eclipsed the breadth of
components initially recommended by the
WHO. These include government commitment
to TB control in the form of financial and
institutional supp0l1, passive case finding and
diagnosis which requires an infrastmcture that
can support laboratory-based diagnosis by
trained personnel, a continuous and reliable
supply of TB dmgs in order to ensure an
unintermpted supply of TB medication. and a
standardized reporting and recording system
(which includes a registry of smear and culture
positives which can be used to chm1 the
demographics and resistance patterns of new
cases) (WHO 1997).
Together, the aforementioned
components along with directly observed
therapy represent a strategy for TB detection,
treatment and control that is based on
substantial financial and political commitment to
program development. National support for the
implementation of "successful" TB control
programs necessitates the allocation of substantial
resources for technical SUpp0l1, the training of
health care workers and support staff, and the
building of infrastmcture to accommodate the
administration of treatment at the regional and
national level. The WHO five-pronged strategy
represents the ideal exemplar of health promotion
initiatives. In reality however, these types of
recommendations are rarely followed to the letter.
This is especially the case in developing countIies
where the technical and human resources needed
to implement a systematic national TB strategy
m'e in short supply. More often than not, the
poorest countries experiencing the highest rates of
TB morbidity and m0l1ality are those which have
the least access to consistent supplies of high-
quality TB dmgs. Meanwhile, the goal of
detecting passive cases of TB also necessitates a
great deal of financial resources and technical
support. Being able to compile a systematic
record of TB patients is also predicated on a
sedentm'y model of human residential patterns.
Such being the case, this type of database
excludes those who live on the margins of
society, for example, nomadic people and the
urban homeless, both of which cannot be
traceable to a pernlanent address. It is also worth
mentioning that the efficacy of the WHO TB
control model is based primm'ily on studies of this
system in politically stable, Western societies.
To date, it has no not been tested in
societies where "social stmctures are fragile and
fragmented as a result of political instability
and/or economic collapse" (Squire & Wilkinson
1998:481). In these specific contexts, TB control
is made all the more challenging because of the
destmction or inefficiency of existing health
infrastIUcture and the increased level of infection
due to malnutrition and sub-standard living
conditions. Thus, it is important when evaluating
TB control programs, to consider the fact that the
DOTS strategy represents more than a model for
the supervised ingestion of dmgs. Acknowledging
this fact leads us to think about the financial and
technical demands of properly implementing the
five components of the WHO system and
evaluating if this paradigm is really applicable
and accessible to all nations, pm1icularly those in
greatest need and at greatest risk.
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Pandora's Apothecary: of "smoking guns"
and "magic bullets"
In the war against infectious diseases
biomedicine, armed with its arsenal of chemical
curatives has left an enduring legacy on the
state and quality of human health particularly in
the last century. Super bugs, intelligent,
virulent and rapidly mutating and evolving
strains of pathogens have spulTed the need for
super drugs or "magic bullets" as they are
euphemistically refelTed to by their critics. In
turn, this pharmacologically-centered approach
to health and healing has made way for an ever-
growing apothecary of synthesized panaceas to
form the ultimate biochemical offensive in the
ongoing battle between human against disease.
From an anthropological perspective, the
conflict of "man "versus the elements may
conceptually be viewed as one of many "acts"
in the ever-evolving nalTative of culture
(represented by controlled biotechnological
innovation) versus the baneful ills of
uncontrollable nature (epitomized by the disease
pathogen). Enveloped in and inherently a part of
this predominantly Western medical paradigm
exists the biochemical Pandora's box wherein
each prescribed capsule and concoction is
encapsulated with the ideology of 20th century
medicine- that is, the authority and capacity of
positivist, scientifically-based and empirically-
derived means of alleviating (if not curing) any
and all visible and quantifiable symptoms of
dis-ease. And yet, like the fabled Pandora's box
itself, which was at once both a gift (for
containing the world's ills) and a curse (on
account of its inability to indefinjtely do so), the
methodological interventions presclibed and
proscribed within a biomedical framework of
health care and health promotion have a history
of invoking as much trauma as they have
healing. This is evidenced by the high number
of iatrogenic and nosocomial deaths, and our
dependence on biochemical "quick fixes" as
temporary antidotes to an ever-growing list of
"pathologized" life events and conditions.
Emphasis on biochemical solutions for social
diseases reflects the capitalist-informed agenda
of de-politicizing health. Identifying disease
phenomena as conditions that result from
disturbances occurring exclusively at the
biological level precludes any discussion of the
social, economic and political factors that
directly affect health status.
A new wave of sensationalism directed
at increasing our chemico-dependency has
surfaced in the area of TB control. Tern1ed the
"new social disease" by Paul Farmer, the
publicized emergence of "new" multi-resistant
strains of tuberculosis have re-framed the
conceptualization of TB and reintroduced a
biochemical emphasis in the fight against TB in
the last decade. The discourse surrounding the
emergence of highly resistant strains of the
tuberculosis bactelium across the globe present
this problem as one rooted in biology,
specifically, the evolution of a more virulent form
of bacterium which has become resistant to our
CUlTentassortment of TB drugs. In turn, this type
of discourse is utilized by biomedical
practitioners and pharmaceutical companies who
see the creation of a new super-drug or "magic
bullet" as the only logical solution to control the
increase in TB infection around the world. What
is ironic about this type of argument is the fact
that in many cases, increases in TB can be traced
back to the drugs themselves. The emergence of
resistant TB strains is often caused by inmmnity
resulting from the inconsistent administration of
TB drugs, and thus cannot be assumed to be
exclusively reflective of the "natural" evolution of
a more virulent strain of the disease.
Poor access to sufficient supplies of TB
drugs in developing countries is not a new
problem. From tuberculosis and malmia, to the
treatment of AIDS, the issue of inadequate drug
supplies has always problematized both
preventati ve and curative international health
initiatives. Proven treatment programs like DOTS
require large quantities of high-quality drugs,
with especially expensive therapies for drug
resistant strains. Multinational drug companies
are among the most lucrative of business
enterprises. and they have shown no interest in
making their products available to the hundreds of
millions of people infected with the TB bacillus
who are too poor to pay for the drug treatment.
Intellectual property protection, in the form of
patents on essential drugs, and the continued
debates on differential pricing, financing, supply,
selection and distlibution in addition to the
political and economic implications of pm'allel
import of generic drugs represents a network of
drug-related issues that continue to problematize
the implementation of a TB program that can
ensure access to essential drugs to the poor in
developing countries.
Critics of the CUlTent problem of drug
accessibility often point to poorly structured,
ineffectively organized and insufficiently funded
national health systems as the source of inequality
in health care. However, the emphasis on
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institutional and organizational failure may be
seen as yet another means of dismissing the root
of the problem, which is rooted in the political
and economic disparities existing in many
countries and the political and economic
structures that reproduce and sustain these
differences. Thus, it would seem that the goal of
curbing the development of multi-drug resistant
TB strains and controlling the rapid increase in
TB cases lies not in the formulation of a new
"magic bullet", or even in the authorization of
generic "clone" drugs in the global market, but
in the identification and dissolution of deeply-
rooted political and economic inequalities
existing in highly stratified societies that
contribute to the poor health status of the poor
and disenfranchised.
Health = economic productivity model
Like other biomedical initiatives to
improve health, the capitalist ethos colours both
the research design and methodology of studies
into the efficacy of TB eradication programs.
The underlying paradigm for assessing such
initiatives is similar to the "disease hinders
development model" made popular during the
1950's when internationally-funded malaria
eradication strategies were at their peak.
"Progress", "productivity" and other
development-oriented terminology still
proliferate the literature on TB control
strategies. The conflation of health and
productivity is most often seen in biomedical
studies assessing the efficacy of DOTS
infrastructure and initiatives. In short, the
efficacy of the program is measured in terms of
the productivity of the population indexed by
number of days of work lost and number of trips
to the physician. The criticism of this type of
measurement is that quality of life cannot be
extrapolated solely from quantitative, monetary-
based measurements alone such as the GNP and
per capita income used by economists. This
would entail consideration of other important
indices of health and standard of Iiving, such as
family life and cohesion, sense of well-being,
patient satisfaction, frequency of illness relapse,
community health indicators, to name just a
few.
The irresponsible and the ignorant: the politics
of adherence behaviour
The increasing number of critiques of
TB programs by social scientists has turned
emphasis to the behavioural aspects of
individual health-seeking strategies. Although this
may be viewed as another integral step of
understanding disease beyond the biomedical
paradigm, it presents its own set of challenges.
The study of patient adherence to treatment is
premised on the belief that there are certain
"patterns of behaviour" adopted by treatment
"non-compliers". In reality, however there is no
proven set of defining traits of patients who do
not complete their TB treatment. Several authors
(Farmer 200 I; Sumartojo 1990) have taken issue
with the study of patient adherence behaviour. On
the most fundamental level, the terms
"compliance" and "adherence" are value-loaded
in an interesting way. On the one hand, the word
"compliance" has "the unf0l1unate connotation
that the patient is docile and subservient to the
provider" (Farnler 200 I :226). However, on the
other hand, the notions of compliance and
adherence over-exaggerate the patient's agency,
suggesting that all patients possess the ability to
comply- or refuse to comply with anti-
tuberculosis strategies. Exaggerated agency is
illustrated by patients who are counseled to eat
good food, drink clean water, and sleep in
uncrowded living condition. Meanwhile, it is the
lack of these very factors (deriving from wont and
poverty) that make one ill in the first place
(Farmer 2001). Patient non-compliance is often
used by medical practitioners and governmental
agencies to explain program failure, which in
turn, allows for the dismissal and denial of the
structural barriers that lead to the failure of
treatment (Farmer 2001:227).
Those who identify patient ignorance as
the source of patient non-adherence advocate TB
education for TB patients. Disease education is
positive in that it empowers the patient by
demystifying the biological aspects of their
disease and allows for informed consent with
respect to treatment on the part of the patient.
However, these strategies are often underscored
by a tone of paternalism and promote the
infantilism of patients. Meanwhile, there are those
who identify patient irresponsibility as the source
of TB infection, resorting to victim blaming- a
common verbalized persecution of the poor based
upon class-informed stereotypes. Negative and
unsympathetic responses from the medical and
lay community has facilitated the implementation
of punitive measures against TB treatment non-
complier. From "panoptic" models of treatment
such as DOT therapy, to legal sanctions and
incarceration, tuberculosis control serves as an
exemplar of power, punishment and discipline in
the arena of health negotiated along class lines.
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A double- edged sword: culture as an index to
health behaviour
Diametrically opposed to biological
reductionist accounts of disease, social
scientists and anthropologists in particular have
attempted to emphasize the often overlooked
cultural beliefs, value and world views which
inform both the phenomenological aspects of
patient's conceptualization of disease and the
associated behaviours adopted to cope with
their condition. The downside of this form of
analysis is the appropriation of the notion and
word "culture" to varying degrees by those in
different fields, making the definition of the
term "fuzzy" and even more difficult to
operationalize and contextualize. Taking
cultural factors into consideration is
recommended by all who promote the creation
of culturally-sensitive and appropriate health
care. However, overemphasis of cultural aspects
of patient health-seeking behaviour can also
result in the perpetuation of existing injustices
and inequalities. In his seminal work Infections
and Injustices: The Modem Plagues (200 I) Paul
Farmer articulates the danger of over-
emphasizing cultural aspects, pmticularly when
looking for answers to patterns of health
behaviour. In referring to the conflation of
structural violence and the "cultural exotic",
Farmer wishes to remind us how easily
practices that have been identified as differing
between cultures can easily degenerate into
racial stereotypes, prejudices and
discrimination. When "culture" (with a capital
"e") is used as a window dressing to add the
sense of depth to research, it is most often
simultaneously used as a smoke screen to
rationalize program failures as the inevitable
result of cultural incommensurability, rather
than being seen as resulting from material
constraints rooted in political and economic
inequality.
The politics of language- the "re-emergence"
ofTB
Although the biomedical tactic of
avoiding the politicization of disease is not new,
the discursive means elicited to perpetuate the
avoidance of the political and economic
underpinnings of disease has taken a new turn.
The phrase the "re-emergence" of TB insinuates
the return of a disease once conquered, and
relegated to the annals of medical history. In
reality, TB has never ceased to plague the poor,
marginalized and disenfranchised of both
developed and developing worlds. Also
interesting is the "otherness" of TB. Tuberculosis
is seen as disease of the "other", that finds its way
into countries and nations via the travel routes and
trespass of immigrants, refugees and transients,
who come from populations where the disease is
"endemic". These assumptions are heavily
imbued with the notion of biological determinism,
in which "vulnerable" populations are reified as
groups who are "predisposed" to illness to a
celtain degree. As lucidly articulated by Waldram
et al. (1995:263):
"Racial susceptibility to specific
diseases was but one aspect of
the supposition that humankind
could be classified into
biologically distinct units on the
basis of fundamental.
observable, heritable
characteristics. The inability to
mount an effecti ve inmlUne
response to palticular diseases
was one of the features thought
to distinguish 'plimiti ve' from
'civilized' races."
Re-visiting such discourse from our colonial past
can provide us with stark examples of how
arguments founded on existing biological
variation can quickly be manipulated to support
the propaganda of scientific racism.
TB and historical contingency
Anthropological interpretations of
disease share in common the emphasis placed on
the importance of situating and examining disease
phenomena within their social, political,
economic and cultural context. In his analysis of
the health status of present-day Haitians, Paul
Farmer reminds us that it is also important to
consider both present-day structural constraints
and historical contingency when interpreting the
health of a patticular population. In a similar
fashion, Mary Ellen Kelm (1998) addresses the
effects of colonization on aboriginal bodies and
ideological constructions of disease. Both of these
studies share the similar goal of identifying the
effects of colonial history, mm'ginalization,
isolation, segregation and forced cultural
assimilation on the disease history of populations
groups. The influences of racism and notions of
modernization, progress and development are also
imperative when trying to interpret the
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epidemiology of disease in indigenous
populations. Both authors provide convincing
arguments to support the view that diseases
must not be viewed as isolated, discrete or
discontinuous events. Rather, disease events
should be view as biological manifestations of
continuing social and political inequalities.
TB in Aboriginal Populations
The impetus to devise and implement a
"new" national TB eradication strategy in
Canada has resulted from the rise in TB
infections in aboIiginal communities as a result
of the growing number of patients with
HIV/AIDS-TB co-infection and the emerging
resistance to TB drugs such as Iifampin.
Initiated in 1992 the "National Tuberculosis
Elimination Strategy for AboIiginal Peoples of
Canada" is the result of the collaboration of
several agencies, including the first Nations and
Inuit Health Branch (FNIHB) of Health Canada,
the Centre for Infectious Disease Prevention
and Control (CIDPC) of Health Canada and the
Assembly of First Nations (AFN) (Health
Canada 1999). The resolute goal of the strategy
is the reduction of the incidence of TB in
AbOliginal populations to 1 per LOO,OOO by the
year 20 IO. Clinical Management, a TB registry
and a controlled system for TB drug supply and
dispersal are among the key components of TB
control in the strategy representing initiatives
that are centralized at the regional level (Health
Canada 1999). Beyond these centralized
implementations, decentralized strategies have
been initiated through the delivery of pIimary
health care services in First Nations
communities. Constituting the backbone of the
TB eradication strategy at the regional level
include six key courses of action: 1) Case
finding and case holding which involves the
detection of active TB cases in a given
community, to ensure a proper course of
treatment for all patients and the maintenance of
a central registry with records of treatment
outcomes and follow-ups; 2) contact tracing and
directly observed treatment of latent TB
(LTBI); 3) surveillance at the community,
regional and national levels; 4) Bacille
Calmette-GueIin (BCG) immunization in
communities where the use of the vaccine has
been recommended; 5) health education and
training; and finally 6) active research (Health
Canada 1999:5). Despite these recent initiatives,
a summary of the report published in 1999
concludes that although the rates of TB
infection have expelienced an over all decline,
the strategy's target goal of contammg the
incidence of TB to 1 per 100,000 is not expected
to be attained by the projected date of 2010. The
AboIiginal TB eradication strategy is modeled in
the biomedical paradigm of disease. As such,
important political, economic and social health
determinants (i.e. povel1y, marginalization,
racism ... etc) are given little or no consideration.
In addition, cultural diversity is denied through
the homogenization of aboIiginal groups,
reminiscent of the Pan-Indian culture" model of
the early nineteenth century. What is most
interesting, however is the omission of an
important time in aboIiginal Canadian history- the
introduction of residential schools in Canada.
Although the dissemination of TB in
aboIiginal communities is traced back to the
ani val of Europeans in the "New World", framing
the epidemiological history of TB in the "deep
past" precludes the examination of equally
important health-related events in the "recent
past". The residential school expeIience
constitutes an important part of the abOliginal
history of health and disease. One of the most
important reports on the living conditions and
environment of residential schools comes to us
from general medical attendant, Dr. Peter Bryce.
Bryce's report, published in 1908 describes the
dilapidated state of a selies of residential and
industIial schools in the Canadian prairies, and
reports on the alarmingly high levels of TB
morbidity and m0l1ality of residential school
students. In her chapter on residential schools,
Kelm desClibes equally disturbing trends. A
department survey of schools in 1939 estimated
that at least 5% of all residential schools students
in BC were suffeIing from active TB (Kelm
1998:67). A study conducted just a year later
concluded that 70% of all Aboriginal children in
residential schools reacted positively to the
tuberculin test (Kelm 1998:67). Kelm's chapter
provides a succinct summary of the various health
determinants that facilitated the Oligin and spread
of TB in these environments. These included:
malnutlition, sub-standard living conditions, the
consumption of milk from cows infected with the
TB bacillus, stlingent working conditions and the
enrolment of children already suffeIing from a
wide array of illnesses (Kelm 1998:66-67).
Although historical descIiptions of TB are
insightful, they fail to give us a holistic view of
the legacy of the disease. What has hitherto been
overlooked is the legacy of TB in Canadian
residential schools, and how these expeliences
relate to CUlTentprevalence of TB in Aboriginal
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populations, who are still 10 times more likely
to contract TB than non-aboriginal Canadians
(Health Canada 1999). How did the residential
school experience affect both the biological
constitution and the ideological illness
constructions of aboriginal people? How did
residential schools function as both loci and
vectors of TB? What implications would an
understanding of the residential school
experience and TB have on present TB control
initiatives? These are questions that walTant
analysis if TB is to be controlled in Aboriginal
populations.
The stronghold of the Western
biomedical paradigm on the conceptualization
and interpretation of health and well-being has
presented an unresolved quandary in both the
spheres of academia and public health.
Consensus on the efficacy of biomedical theory
and praxis, in turn serves to support and
legitimize the formulation of genelic,
homogenized health care policies which are
characterized by a uniformity of objectives,
rationale and procedure to form models which
are presumably universal in their applicability
and projected efficacy.
This essay has attempted to show how
the hegemony of the biomedical paradigm in
TB control strategies has precluded
consideration of important health determinants
emerging from the political, economic and
social spheres by deconstructing CUlTent TB
initiatives, primarily the WHO's DOTS
strategy. The application of theoretical models
such as critical medical anthropology can be
used to offer both critiques of ~the existing
features of TB strategies and counter-critiques
of existing conmlentary on the status and
efficacy of TB control initiatives. The
importance of historical contingency on the
health of populations was illustrated by a case
example that looked at residential schools as the
locus of physiological and psychological
disease processes. If one important point can be
extracted from this reflection on the legacy of a
disease, it would be that our ethnocentric
assumptions regarding the superiority of
Western medicine continue to permeate health
strategies and delivery, to the detriment of non-
Western populations. If the efficacy, or rather
inefficacy of CUlTentTB strategies is any clue, it
becomes obvious that motivations that drive
Western medicine's plivate vices and public
virtues in the realm of health are quickly
making what Haig-Brown (1998) has coined
"victims of benevolence" of those who our
strategies are meant to help and not harm.
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